BenchSci vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
BenchSci is an AI-powered biomedical research intelligence platform used by 16 of the top 20 pharma companies; accelerates experiment design by analyzing millions of scientific papers and proprietary data to recommend validated reagents and.
About
BenchSci is a Toronto-based life sciences AI company founded in 2015 by Tom Leung, Elvis Wianda, Liran Belenzon, and David Chen. The company builds AI-powered research intelligence software that helps biomedical scientists — particularly at pharmaceutical and biotechnology companies — design better experiments faster, reduce failure rates, and avoid duplicating work that has already been done. BenchSci''s platform applies machine learning to analyze both published scientific literature (including open-access and licensed journal databases) and proprietary experimental data from its pharma clients, extracting structured information about reagent performance, experimental protocols, and biological targets to generate recommendations for researchers planning new experiments.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.